DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Tata Chemicals Limited — News Verification

NSE 1 hr ago·29 Sept 2026, 4:38 pm

Tata Chemicals

Tata Chemicals has clarified to the stock exchange that recent market volatility was triggered by a news report regarding the Tata Trusts' proposal to reduce their stake in Tata Sons. The company confirmed that this proposal, if implemented, could impact the future listing prospects of Tata Sons. Consequently, shares of Tata Chemicals, which hold significant investments in Tata Sons, experienced a decline in value.

For investors, this news highlights the interconnected nature of the Tata Group's business ecosystem. While the company is not directly involved in the proposal, its financial performance is sensitive to the valuation of its major associate, Tata Sons. The clarification aims to provide transparency regarding the source of the market movement.

Investors should monitor the official updates from the Tata Group and the Trusts regarding the stake reduction plan. The final outcome of this proposal will determine the long-term impact on the valuation of Tata Sons and, by extension, on the financial statements of its major investees like Tata Chemicals.